Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spagnoli

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Cancer Gene Therapy|October 11, 2001
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigenA Schütz, D Oertli, W R Marti, et al.
World Journal of Surgery|February 1, 1997
Increased surface expression of CD18 and CD11b in leukocytes after tourniquet ischemia during elective hand surgeryP M Sutter, G C Spagnoli, A Marx, et al.
Human Gene Therapy|April 7, 2005
Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responsesChantal Feder-Mengus, Elke Schultz-Thater, Daniel Oertli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferationA Funaro, G C Spagnoli, C M Ausiello, et al.
Frontiers in Medicine|March 25, 2017
MAGE-A Antigens and Cancer ImmunotherapyPaul Zajac, Elke Schultz-Thater, Luigi Tornillo, et al.
International Journal of Cancer|November 6, 2012
MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomasChantal Mengus, Elke Schultz-Thater, Julie Coulot, et al.
Vaccine|September 17, 2005
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitroReto Schumacher, Mario Amacker, Danielle Neuhaus, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1997
Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanomaM Zuber, G C Spagnoli, T Kocher, et al.
International Journal of Cancer|June 22, 2000
Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2C Noppen, F Lévy, L Burri, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2004
Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cellsAntonella Cavazza, Michel Adamina, Clara M Ausiello, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Cancer Gene Therapy|October 11, 2001
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigenA Schütz, D Oertli, W R Marti, et al.
World Journal of Surgery|February 1, 1997
Increased surface expression of CD18 and CD11b in leukocytes after tourniquet ischemia during elective hand surgeryP M Sutter, G C Spagnoli, A Marx, et al.
Human Gene Therapy|April 7, 2005
Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responsesChantal Feder-Mengus, Elke Schultz-Thater, Daniel Oertli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferationA Funaro, G C Spagnoli, C M Ausiello, et al.
Frontiers in Medicine|March 25, 2017
MAGE-A Antigens and Cancer ImmunotherapyPaul Zajac, Elke Schultz-Thater, Luigi Tornillo, et al.
International Journal of Cancer|November 6, 2012
MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomasChantal Mengus, Elke Schultz-Thater, Julie Coulot, et al.
Vaccine|September 17, 2005
Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitroReto Schumacher, Mario Amacker, Danielle Neuhaus, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1997
Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanomaM Zuber, G C Spagnoli, T Kocher, et al.
International Journal of Cancer|June 22, 2000
Naturally processed and concealed HLA-A2.1-restricted epitopes from tumor-associated antigen tyrosinase-related protein-2C Noppen, F Lévy, L Burri, et al.
Clinical Immunology (Orlando, Fla.)|June 9, 2004
Hydrolysis of the tumor-associated antigen epitope gp100(280-288) by membrane-associated and soluble enzymes expressed by immature and mature dendritic cellsAntonella Cavazza, Michel Adamina, Clara M Ausiello, et al.
Pageof 19